Advertisement

Corrigendum to “EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis” [J Hepatol 69 (2018) 406–460]

Published:August 29, 2018DOI:https://doi.org/10.1016/j.jhep.2018.08.009

      Linked Article

      • EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
        Journal of HepatologyVol. 69Issue 2
        • Preview
          The natural history of cirrhosis is characterised by an asymptomatic compensated phase followed by a decompensated phase, marked by the development of overt clinical signs, the most frequent of which are ascites, bleeding, encephalopathy, and jaundice. The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis. In this context, the panel of experts, having emphasised the importance of initiating aetiologic treatment for any degree of hepatic disease at the earliest possible stage, extended its work to all the complications of cirrhosis, which had not been covered by the European Association for the Study of the Liver guidelines, namely: ascites, refractory ascites, hyponatremia, gastrointestinal bleeding, bacterial infections, acute kidney injury, hepatorenal syndrome, acute-on-chronic liver failure, relative adrenal failure, cirrhotic cardiomyopathy, hepatopulmonary syndrome, and porto-pulmonary hypertension.
        • Full-Text
        • PDF
      It has come to our attention that there is an error in the original manuscript in the section entitled ‘Renal impairment’ on page 429. The sentence ‘Recent studies have suggested that in patients with cirrhosis, in AKI stage 1, SCr <1.5 mg/dl is associated with a worse outcome than an SCr ≥1.5 mg/dl.’ should read ‘Recent studies have suggested that in patients with cirrhosis, in AKI stage 1, SCr ≥1.5 mg/dl is associated with a worse outcome than an SCr <1.5 mg/dl’. We apologise for this mistake and any inconvenience caused.